BIO Stock Overview
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIOTON S.A. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||zł3.88|
|52 Week High||zł4.10|
|52 Week Low||zł3.26|
|1 Month Change||-2.39%|
|3 Month Change||6.90%|
|1 Year Change||6.75%|
|3 Year Change||-8.82%|
|5 Year Change||-32.61%|
|Change since IPO||-96.85%|
Recent News & Updates
|BIO||PL Biotechs||PL Market|
Return vs Industry: BIO exceeded the Polish Biotechs industry which returned 3% over the past year.
Return vs Market: BIO underperformed the Polish Market which returned 27.2% over the past year.
|BIO Average Weekly Movement||2.4%|
|Biotechs Industry Average Movement||4.8%|
|Market Average Movement||5.0%|
|10% most volatile stocks in PL Market||10.1%|
|10% least volatile stocks in PL Market||3.2%|
Stable Share Price: BIO is less volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: BIO's weekly volatility (2%) has been stable over the past year.
About the Company
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
|BIO fundamental statistics|
Is BIO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BIO income statement (TTM)|
|Cost of Revenue||zł123.94m|
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 31, 2023
|Earnings per share (EPS)||0.051|
|Net Profit Margin||2.00%|
How did BIO perform over the long term?See historical performance and comparison